5 portfolio moves to make now that could pay off this year
Expect lower interest rates, tech-sector growth and international-stock gains in 2026. Here's why.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Bitcoin bulls avoided a correction as US markets opened, but analysis warned that Strategy was responsible for much of the latest BTC price strength.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesExpect lower interest rates, tech-sector growth and international-stock gains in 2026. Here's why.
CINCINNATI, January 08, 2026--Forbes evaluated company size data along with ratings and reviews from both customers and employees
MILWAUKEE, January 08, 2026--Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology, today announced a strate...
Non-custodial crypto wallet SafePal has joined hands with decentralised lending network Morpho to improve access to risk-adjusted stablecoin yield and enha...
Memory Supply Is Sold Out for 2026. Micron Could Be One of the Biggest Winners
The proposal reduces Florida's crypto ambitions, effectively limiting eligible assets to Bitcoin and distancing it from pension exposure.
Buffett's legendary investing record reveals a hard truth about the stock market.
New York's Cooper Union settles campus antisemitism case, pledges reforms
American Electric Power signs $2.65 billion deal for fuel cells
Economic rebuilding depends on the U.S. lifting sanctions. The wait for Venezuela - and U.S. companies - could be long.
Analyst flags Tesla as robotaxi leader, targets 40% stock upside
MoonLake stock soars after FDA feedback on HS treatment path